Vinod Swarna, MS, MCA

home / authors / vinod-swarna-ms-mca

Articles

Oral Oncology: Utilization of Selected Oral Antineoplastic Enzyme Inhibitor Agents

Anna A. Theodorou, RPh, MBA;Anthony Palmieri, PharmD, RPh, MBA;John A. Szychowski, AAS, BS;Marina L. Sehman, PharmD, RPh;Vinod Swarna, MS, MCA

August 2nd 2012

An overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.

Prescription Utilization of the Oral Anticoagulants

Anna A. Theodorou, RPh, MBA;Anthony Palmieri, PharmD, MBA, RPh;John A. Szychowski, AAS, BS;Marina L. Sehman, RPh, PharmD;Vinod Swarna, MS, MCA

May 31st 2012

New and forthcoming oral anticoagulants, which do not require prothrombin time monitoring, will offer patients and providers additional therapeutic options.

Initial Prescription Utilization of the New Hepatitis C Agents

Anna A. Theodorou, RPh, MBA;John A. Szychowski, AAS, BS;Marina L. Sehman, RPh, PharmD;Vinod Swarna, MS, MCA

April 5th 2012

Incivek and Victrelis, approved for Hepatitis C within weeks of each other in May 2011, look to change the way the disease is treated.